CTAs keep buying Treasuries, gold longs face stop-loss risk: BofA
Coliseum Capital, a ten-percent owner of Owens & Minor INC/VA/ (NYSE:OMI), has recently purchased shares of the company worth approximately $8.1 million. These purchases, executed between August 12 and August 14, 2025, involved the acquisition of 1,537,852 shares.
The purchases were made at prices ranging from $5.15 to $5.46. Specifically, on August 12, Coliseum Capital acquired 720,000 shares; on August 13, 325,000 shares; and on August 14, 492,852 shares.
Following these transactions, Coliseum Capital’s total holdings in Owens & Minor common stock amounted to 13,100,807 shares. The shares are held by Coliseum Capital Partners, L.P. ("CCP"), Coliseum Capital, LLC, and a separate account investment advisory client of Coliseum Capital Management, LLC. Christopher S. Shackelton and Adam Gray, managers of Coliseum Capital Management, LLC, disclaim beneficial ownership of the securities except to the extent of their pecuniary interest.
In other recent news, Owens & Minor reported its second-quarter 2025 earnings, which showed a mixed financial performance. The company announced earnings per share of $0.26, falling short of the analysts’ forecast of $0.29, representing a 10.34% miss. Despite this, revenue for the quarter increased to $682 million, marking a 3.3% rise compared to the previous year. UBS responded to these results by lowering its price target for Owens & Minor from $13.00 to $7.00, although it maintained a Buy rating. The firm cited the impact of near-term dis-synergies from the sale of Patient & Healthcare Services and the loss of Kaiser on 2026 EBIT as reasons for the price target reduction. UBS also noted that the potential proceeds from the P&HS sale, estimated at approximately $700 million, could help Owens & Minor reduce its debt. These developments reflect recent challenges and strategic shifts within the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.